Evogene Stock Price Patterns
| EVGN Stock | USD 1.09 0.01 0.93% |
Momentum 51
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.41) | EPS Estimate Current Year (0.62) | EPS Estimate Next Year (1.35) | Wall Street Target Price 2.5 | Quarterly Revenue Growth (0.83) |
Using Evogene hype-based prediction, you can estimate the value of Evogene from the perspective of Evogene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evogene to buy its stock at a price that has no basis in reality. In that case, they are not buying Evogene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evogene after-hype prediction price | USD 1.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Evogene Basic Forecasting Models to cross-verify your projections. Evogene After-Hype Price Density Analysis
As far as predicting the price of Evogene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evogene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Evogene, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evogene Estimiated After-Hype Price Volatility
In the context of predicting Evogene's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evogene's historical news coverage. Evogene's after-hype downside and upside margins for the prediction period are 0.05 and 4.70, respectively. We have considered Evogene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evogene is dangerous at this time. Analysis and calculation of next after-hype price of Evogene is based on 3 months time horizon.
Evogene Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Evogene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evogene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evogene, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 3.61 | 0.00 | 0.01 | 6 Events / Month | 2 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.09 | 1.09 | 0.00 |
|
Evogene Hype Timeline
Evogene is currently traded for 1.09. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Evogene is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.08%. %. The volatility of related hype on Evogene is about 2865.08%, with the expected price after the next announcement by competition of 1.10. The company recorded a loss per share of 1.1. Evogene had not issued any dividends in recent years. The entity had 1:10 split on the 25th of July 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Evogene Basic Forecasting Models to cross-verify your projections.Evogene Related Hype Analysis
Having access to credible news sources related to Evogene's direct competition is more important than ever and may enhance your ability to predict Evogene's future price movements. Getting to know how Evogene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evogene may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GOVX | GeoVax Labs | 0.65 | 8 per month | 0.00 | (0.28) | 9.38 | (13.70) | 42.89 | |
| BLRX | BioLineRx | 0.07 | 6 per month | 0.00 | (0.08) | 4.95 | (5.26) | 13.04 | |
| THAR | Tharimmune | (0.15) | 9 per month | 5.94 | 0.05 | 11.15 | (10.08) | 29.73 | |
| AIMD | Ainos Inc | 0.06 | 9 per month | 0.00 | (0.11) | 12.30 | (10.43) | 38.73 | |
| LPCN | Lipocine | 0.00 | 6 per month | 3.28 | 0.30 | 15.95 | (7.33) | 33.09 |
Evogene Additional Predictive Modules
Most predictive techniques to examine Evogene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evogene using various technical indicators. When you analyze Evogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evogene Predictive Indicators
The successful prediction of Evogene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evogene, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evogene based on analysis of Evogene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evogene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evogene's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.25 | 2.23 | 2.01 | 2.11 | Revenue Per Share | 0.12 | 1.47 | 1.69 | 1.77 |
Pair Trading with Evogene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evogene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will appreciate offsetting losses from the drop in the long position's value.Moving against Evogene Stock
| 0.74 | DSGN | Design Therapeutics | PairCorr |
| 0.61 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.55 | ENGN | enGene Holdings Common | PairCorr |
| 0.5 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.37 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Evogene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evogene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evogene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evogene to buy it.
The correlation of Evogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evogene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evogene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evogene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Evogene Basic Forecasting Models to cross-verify your projections. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Will Biotechnology sector continue expanding? Could Evogene diversify its offerings? Factors like these will boost the valuation of Evogene. Projected growth potential of Evogene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Evogene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.10) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets | Return On Equity |
Investors evaluate Evogene using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Evogene's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Evogene's market price to deviate significantly from intrinsic value.
It's important to distinguish between Evogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Evogene's market price signifies the transaction level at which participants voluntarily complete trades.